MHRA

mceu_66629070011658413126217.jpg bookmark_icon_off
Public health

Stocks of insulin product run out while MHRA recalls eye drop batch

Stocks of Insuman Comb 50 100units/ml suspension for injection 3ml cartridges have been exhausted.

1 Min Article

Social media 1280.jpg bookmark_icon_off
Clinical services

MHRA warns companies against online advertising of Kenalog injections

Kenalog injections are not licensed for the treatment of hay fever in the UK

1 Min Article

common cold summary.jpg bookmark_icon_off
Regulations

MHRA approves POM to P switch for Sudafed Plus Blocked Nose nasal spray

The product will be available from pharmacies without a prescription following the reclassification

1 Min Article

Earth 1280.jpg bookmark_icon_off
Legal

MHRA seized nearly £1m worth of illegally sold medicines

Anti-depressants, erectile dysfunction tablets, painkillers, anabolic steroids and slimming pills were recovered in the UK.

1 Min Article

woman sofa summary.jpg bookmark_icon_off
Women's health

MHRA announces ‘landmark’ POM to P switch for Gina 10mcg tablets

The product will be available following a consultation with a pharmacist.

1 Min Article

Recall 1280.jpg bookmark_icon_off
Practice

Quadrant recall batch of mefenamic acid tablets

Batch number 107082 found to have a defective layer of film coating.

1 Min Article

Recall 1280.jpg bookmark_icon_off

Pfizer recalls batches of Accupro over potential safety risk

Batches found to contain potentially dangerous levels of an organic compound that could cause cancer.

1 Min Article

Recall 1280.jpg bookmark_icon_off
Public health

MHRA recalls two drugs in two days

A batch of sodium bicarbonate 1.26 per cent solution for infusion and Paroxetine 40mg film coated tablets were recalled.

1 Min Article

overactive bladder, summary.jpg bookmark_icon_off
Women's health

Mixed reaction to proposed oxybutynin POM to P switch

Some pharmacists have criticised a proposal to reclassify the drug for overactive bladder in women.

2 Min Article

pregabalin summary.jpg bookmark_icon_off
Medication safety

MHRA highlights Nordic pregabalin risk study

Slightly higher risk of major congenital malformations when pregabalin is taken in pregnancy.

1 Min Article

Loading